Documenti di Didattica
Documenti di Professioni
Documenti di Cultura
JT Elder et al.
Immunology and Genetics of Psoriasis
JT Elder et al.
Immunology and Genetics of Psoriasis
HBD-2
Epidermis
Dermis
CD103+
CD49a+
T cell
IL-17+
CD8+
T cells
IL-17
IFN-
IL-17+
T cells
Expansion
APC
IL-17+
T cells
Resident
IL-17+
T cells
IL-23, IL-1
CCL-20
Blood
IL-17+CCR6+
T cells
Figure 1. Proposed mechanism for Th1-mediated support of IL-17-producing
T cells. Th1 cells produce IFN-g, which stimulates myeloid antigen-presenting
cells (APCs) to secrete IL-23. Together with IL-1, IL-23 promotes the survival
and expansion of CD4 and CD8 T cells expressing IL-17. (The same
mechanism expands to a largely non-overlapping population of T cells
expressing IL-22, not shown). The entry of IL-17- and IL-22-producing CD8
T cells into the epidermis promotes epidermal hyperplasia and an innate
keratinocyte defense response involving proteins such as human b-defensin 2
(HBD-2), which are highly overexpressed in psoriasis. Obtained with
permission from Kryczek et al., 2008.
JT Elder et al.
Immunology and Genetics of Psoriasis
JT Elder et al.
Immunology and Genetics of Psoriasis
20
log10 (P-value)
HLAc
15
10
IL12B
TNIP1
IL13 TNFAIP3
IL23R
5
IL23A
0
1
log10 (P-value)
20
15
10
11
12
13
14
15
16
17 18 19 20 21 22
All SNPs
W/o MHC SNPs
W/o all SNPs in replicated regions
10
5
0
0
2
3
4
log10 (expected P-value under null)
Figure 2. Results of the discovery phase of the Collaborative Association Study of Psoriasis genome-wide association study. The upper panel
is a Manhattan plot summarizing the association results obtained for 438,670 genotyped single-nucleotide polymorphisms (SNPs), plotted against
chromosomal position. Seven of the 19 regions that were followed up yielded convincing evidence of association in the replication study, as indicated by
green coloration. The lower panel presents a quantilequantile plot comparing observed versus expected P-values obtained for the 438,670 genotyped
SNPs. Red symbols represents all SNPs, orange symbols represent the results after excluding major histocompatibility complex (MHC) SNPs, and blue symbols
represent the results after excluding SNPs at all replicated loci. The gray area represents the 90% confidence interval expected under a null distribution
of P-values. Note that all panels are truncated at a log10(P-value) of 20; markers near HLA-C exceed this threshold considerably (PE1053). Adapted from
Nair et al., 2009b, with permission.
HLA-Cw6
JT Elder et al.
Immunology and Genetics of Psoriasis
JT Elder et al.
Immunology and Genetics of Psoriasis
NF-jB signaling
A20 and ABIN1 are the products of the TNFAIP3 and TNIP1
genes, respectively. These proteins interact with each other
and participate in the ubiquitin-mediated destruction of IKKg/
NEMO, thereby regulating a key nexus of NF-kB signaling
(Mauro et al., 2006). The degradation of several other
components of the TNF signaling pathway is also regulated
by A20 (Mauro et al., 2006). TNF-a blockade markedly
improves psoriasis-like pathology in a mouse model of
psoriasis induced by injection of IL-23 (Chan et al., 2006),
and a region of mouse chromosome 10 containing Tnfaip3
promotes psoriasis in a TNF-a-dependent manner in another
mouse model (Wang et al., 2008). Given that atherosclerosis
is a major co-morbidity of psoriasis (Gelfand et al., 2006), it is
notable that susceptibility to atherosclerosis has also been
associated with the same region of mouse chromosome 10
(Idel et al., 2003). Moreover, SNPs near TNFAIP3 yield
genome-wide significant associations with rheumatoid
arthritis (Plenge et al., 2007; Thomson et al., 2007) and
systemic lupus erythematosus (Graham et al., 2008; Musone
et al., 2008). These polymorphisms were not associated with
psoriasis in the CASP study (all P40.30) and are not in LD
with the psoriasis-associated alleles (r2o0.03), suggesting
that different alleles of TNFAIP3 increase susceptibility to
systemic lupus erythematosus, rheumatoid arthritis, and
psoriasis. Given that each of these diseases can be associated
with arthritis, it is interesting that the NF-kB inhibitor
parthenolide abrogated IL-23-mediated stimulation of receptor activator of NF-kB (RANK) ligand on CD4 T cells in an
arthritogenic mouse model (Ju et al., 2008).
Tissue macrophages also have an important role in mouse
models of psoriasis, even in the absence of T cells (Stratis
et al., 2006; Wang et al., 2006). As many events in
macrophage and dendritic cell (DC) activation and function
are NF-kB dependent, genetic variation in TNFAIP3 and
TNIP1 could influence the balance between a self-limited
response in which tolerance is eventually restored, and a selfsustaining one in which it is not. Clonal expansion of T cells
requires the active participation of APC, especially DCs,
which are intimately involved in the regulation of immunological tolerance at least in part through the Ag-specific
stimulation of regulatory T cells (Yamazaki and Steinman,
2009). As discussed below, an increasingly complex network
of resident and inflammatory DCs with tolerogenic as well as
immunostimulatory capacities is emerging in psoriasis and
other inflammatory skin disorders.
IL-23 signaling
Three psoriasis-associated genetic signals map to components of the IL-23 ligandreceptor complex (Nair et al.,
2009b). One is found near IL12B (which encodes the p40
subunit common to IL-23 and IL-12), another is located near
IL23A (which encodes the p19 subunit of IL-23), and a third
resides near IL23R (which encodes a subunit of the IL-23
receptor). This was the first study to implicate genetic variants
near IL23A as conferring susceptibility to any human
autoimmune disorder. IL-23 signaling promotes cellular
immune responses by promoting the survival and expansion
JT Elder et al.
Immunology and Genetics of Psoriasis
JT Elder et al.
Immunology and Genetics of Psoriasis
KC
Tc17
Tc17
HLA-Cw6
Tc17
Defensin,
psoriasin, etc.
Tc1
Tc1
Th1
Th2
DC
IL4/IL13
IL23R
Pathogens
Th17
Th1
TNF
TLR
TNFAIP3
Th17
TNIP1
IL23A
IL12B
DC
DC
IFN-
M
NF-B
Figure 3. Model integrating the genetics and immunology of psoriasis. Genes identified as psoriasis-associated by the Collaborative Association Study of
Psoriasis genome-wide association study are italicized. The majority of dermal T cells are CD4 (purple); most of these are Th1, but B5% of them
produce IL-17 (Th17, yellow halo). Most epidermal T cells are CD8 (green circles) and about 5% of them express IL-17 (Tc17, yellow halo). Upper
right panelHLA-Cw6 may increase susceptibility to psoriasis by presenting antigens to CD8 T cells from the surface of dendritic cells (DCs, blue),
and/or by presenting keratinocyte antigens to activated CD8 T cells. As indicated by the partial yellow halo, some of these T cells may express IL-17.
Lower right panelmacrophages (Mfs, orange) and DCs express TNF receptors and Toll-like receptors (TLRs) that signal through IKK-g to promote translocation
of NF-kB to the nucleus. The proteins encoded by TNFAIP3 (A20) and TNIP1 (ABIN1) are capable of binding to each other, and cooperatively block this
signaling by altering patterns of protein ubiquitylation. Lower left panelIL23A and IL12B encode the subunits of IL-23. IL23R encodes one subunit of the
receptor for IL-23. IL4 and IL13 may participate in psoriasis by directly skewing the differentiation of CD4 T cells toward Th2, or by altering the cytokine
profile of DCs in such a way as to favor Th1 differentiation. As shown in Figure 1, Th1 cells stimulate the production of IL-23 by DCs. In turn, IL-23 stimulates
the production of IL-17 and/or IL-22 by Th17 cells. Upper left panelIL-17 and IL-22 upregulate keratinocyte innate immune defense mechanisms, including
defensins, psoriasin (S100A7), and other proteins that are highly expressed in psoriasis lesions. In addition, IL-22 may promote keratinocyte proliferation
and/or alter keratinocyte differentiation. Reproduced from Nair et al., 2009a, with permission.
JT Elder et al.
Immunology and Genetics of Psoriasis
ACKNOWLEDGMENTS
We gratefully acknowledge the important contributions of Dr Ilona Kryczek,
Dr Weiping Zou, and Mr Jun Ding to the research presented in this review.
Research by the authors was supported by awards from the National Institute
of Arthritis, Musculoskeletal, and Skin Diseases, the National Institutes of
Health, the Ann Arbor VA Hospital, the Dudley and Dawn Holmes Fund, the
Babcock Memorial Trust, the National Psoriasis Foundation, the Dermatology
Foundation, the American Skin Association, and by an award (M01 RR00042)
from the National Center for Research Resources, National Institutes of
Health, to the University of Michigan General Clinical Research Center.
REFERENCES
Abrams JR, Kelley SL, Hayes E, Kikuchi T, Brown MJ, Kang S et al. (2000)
Blockade of T lymphocyte costimulation with cytotoxic T lymphocyteassociated antigen 4-immunoglobulin (CTLA4Ig) reverses the cellular
pathology of psoriatic plaques, including the activation of keratinocytes,
dendritic cells, and endothelial cells. J Exp Med 192:68194
Akagi Y, Kimura T, Kunimoto M, Kuki K, Tabata T (1992) A role of tonsillar
lymphocyte for focal infection. With special reference to lymphocyte
adhesion to vessels in dermis. Adv Otorhinolaryngol 47:12933
Altmuller J, Palmer LJ, Fischer G, Scherb H, Wjst M (2001) Genomewide
scans of complex human diseases: true linkage is hard to find. Am J Hum
Genet 69:93650
Baadsgaard O, Gupta AK, Taylor RS, Ellis CN, Voorhees JJ, Cooper KD (1989)
Psoriatic epidermal cells demonstrate increased numbers and function of
non-Langerhans antigen-presenting cells. J Invest Dermatol 92:1905
Baker BS, Laman JD, Powles A, van der Fits L, Voerman JS, Melief MJ et al.
(2006) Peptidoglycan and peptidoglycan-specific Th1 cells in psoriatic
skin lesions. J Pathol 209:17481
Chang JC, Smith LR, Froning KJ, Schwabe BJ, Laxer JA, Caralli LL et al. (1994)
CD8+ T cells in psoriatic lesions preferentially use T-cell receptor V beta
3 and/or V beta 13.1 genes. Proc Natl Acad Sci USA 91:92826
JT Elder et al.
Immunology and Genetics of Psoriasis
Gladman DD, Anhorn KA, Schachter RK, Mervart H (1986) HLA antigens in
psoriatic arthritis. J Rheumatol 13:58692
Gladman DD, Shuckett R, Russell ML, Thorne JC, Schachter RK (1987)
Psoriatic arthritis (PSA) an analysis of 220 patients. Q J Med 62:12741
Gottlieb SL, Gilleaudeau P, Johnson R, Estes L, Woodworth TG, Gottlieb AB
et al. (1995) Response of psoriasis to a lymphocyte-selective toxin
(DAB389IL-2) suggests a primary immune, but not keratinocyte,
pathogenic basis. Nat Med 1:4427
Graham RR, Cotsapas C, Davies L, Hackett R, Lessard CJ, Leon JM et al.
(2008) Genetic variants near TNFAIP3 on 6q23 are associated with
systemic lupus erythematosus. Nat Genet 40:105961
Gudjonsson JE, Ding J, Li X, Nair RP, Tejasvi T, Qin ZS et al. (2009)
Global gene expression analysis reveals evidence for decreased lipid
biosynthesis and increased innate immunity in uninvolved psoriatic skin.
J Invest Dermatol, e-pub ahead of print 2 July 2009.
Gudjonsson JE, Elder JT (2007a) Psoriasis. In: Fitzpatricks Dermatology in
General Medicine (Wolff K, Goldsmith LA, Katz SI, Gilchrest BA, Paller
AM, Leffell DJ, eds). Vol. 1, New York: McGraw-Hill, 16994
Gudjonsson JE, Elder JT (2007b) Psoriasis: epidemiology. Clin Dermatol
25:53546
Gudjonsson JE, Johnston A, Sigmundsdottir H, Valdimarsson H (2004)
Immunopathogenic mechanisms in psoriasis. Clin Exp Immunol 135:18
Elder JT, Nair RP, Guo SW, Henseler T, Christophers E, Voorhees JJ (1994) The
genetics of psoriasis. Arch Dermatol 130:21624
Gudjonsson JE, Thorarinsson AM, Sigurgeirsson B, Kristinsson KG, Valdimarsson H (2003) Streptococcal throat infections and exacerbation of
chronic plaque psoriasis: a prospective study. Br J Dermatol 149:5304
Elder JT, Nair RP, Henseler T, Jenisch S, Stuart P, Chia N et al. (2001) The
genetics of psoriasis 2001: the odyssey continues. Arch Dermatol
137:144754
Ellis CN, Gorsulowsky DC, Hamilton TA, Billings JK, Brown MD, Headington
JT et al. (1986) Cyclosporine improves psoriasis in a double-blind study.
JAMA 256:31106
Espinoza LR, Vasey FB, Gaylord SW, Dietz C, Bergen L, Bridgeford P et al.
(1982) Histocompatibility typing in the seronegative spondyloarthropathies: a survey. Semin Arthritis Rheum 11:37581
Gupta MA, Schork NJ, Gupta AK, Kirkby S, Ellis CN (1993) Suicidal ideation
in psoriasis. Int J Dermatol 32:18890
Fan X, Yang S, Huang W, Wang ZM, Sun LD, Liang YH et al. (2008) Fine
mapping of the psoriasis susceptibility locus PSORS1 supports HLA-C as
the susceptibility gene in the Han Chinese population. PLoS Genet
4:e1000038
Feng BJ, Soltani-Arabsahi R, Bowcock AM, Nair R, Elder JT, Schrodi SJ et al.
(2009) Multiple loci within the major histocompatibility complex confer
risk of psoriasis [abstract]. J Invest Dermatol 129:S85
Fischer J (2001) Analysis of 46 Large Multiplex Families: Genome-Wide
Scan, Candidate Genes and HLA. Stockholm: National Psoriasis
Foundation
Frohm M, Agerberth B, Ahangari G, Stahle-Backdahl M, Liden S, Wigzell H
et al. (1997) The expression of the gene coding for the antibacterial
peptide LL-37 is induced in human keratinocytes during inflammatory
disorders. J Biol Chem 272:1525863
Gardembas-Pain M, Ifrah N, Foussard C, Boasson M, Saint Andre JP, Verret JL
(1990) Psoriasis after allogeneic bone marrow transplantation [letter].
Arch Dermatol 126:1523
Gelfand JM, Gladman DD, Mease PJ, Smith N, Margolis DJ, Nijsten T et al.
(2005) Epidemiology of psoriatic arthritis in the population of the United
States. J Am Acad Dermatol 53:573
Gelfand JM, Neimann AL, Shin DB, Wang X, Margolis DJ, Troxel AB (2006)
Risk of myocardial infarction in patients with psoriasis. JAMA
296:173541
Ghoreschi K, Thomas P, Breit S, Dugas M, Mailhammer R, van Eden W et al.
(2003) Interleukin-4 therapy of psoriasis induces Th2 responses and
improves human autoimmune disease. Nat Med 9:406
Iordanov MS, Sundholm AJ, Simpson EL, Hanifin JM, Ryabinina OP, Choi RJ
et al. (2005) Cell death-induced activation of epidermal growth factor
receptor in keratinocytes: implications for restricting epidermal damage
in dermatitis. J Invest Dermatol 125:13442
www.jidonline.org 1223
JT Elder et al.
Immunology and Genetics of Psoriasis
Nair RP, Ding J, Duffin KC, Helms C, Voorhees JJ, Krueger GG et al. (2009a)
Psoriasis bench to bedside: genetics meets immunology. Arch Dermatol
145:4624
Nair RP, Duffin KC, Helms C, Ding J, Stuart PE, Goldgar D et al. (2009b)
Genome-wide scan reveals association of psoriasis with IL-23 and NFkappaB pathways. Nat Genet 41:199204
Lee GR, Fields PE, Griffin TJ, Flavell RA (2003) Regulation of the Th2 cytokine
locus by a locus control region. Immunity 19:14553
Lee YA, Ruschendorf F, Windemuth C, Schmitt-Egenolf M, Stadelmann A,
Nurnberg G et al. (2000) Genomewide scan in German families reveals
evidence for a novel psoriasis-susceptibility locus on chromosome
19p13. Am J Hum Genet 67:10204
Nair RP, Henseler T, Jenisch S, Stuart P, Bichakjian CK, Lenk W et al. (1997)
Evidence for two psoriasis susceptibility loci (HLA and 17q) and two
novel candidate regions (16q and 20p) by genome-wide scan. Hum Mol
Genet 6:134956
Nair RP, Ruether A, Stuart PE, Jenisch S, Tejasvi T, Hiremagalore R et al.
(2008b) Polymorphisms of the IL12B and IL23R genes are associated
with psoriasis. J Invest Dermatol 128:165361
JT Elder et al.
Immunology and Genetics of Psoriasis
Nair RP, Stuart P, Henseler T, Jenisch S, Chia NV, Westphal E et al. (2000)
Localization of psoriasis-susceptibility locus PSORS1 to a 60-kb interval
telomeric to HLA-C. Am J Hum Genet 66:183344
Nair RP, Stuart PE, Hiremagalore R, Kullavanijaya P, Tejasvi T, Voorhees JJ
et al. (2009c) Analysis of the HLA-Cw1-B46 psoriasis risk haplotype
reveals allelic heterogeneity with HLA-Cw6 [abstract]. J Invest Dermatol
129:S82
Nair RP, Stuart PE, Nistor I, Hiremagalore R, Chia NV, Jenisch S et al. (2006)
Sequence and haplotype analysis supports HLA-C as the psoriasis
susceptibility 1 gene. Am J Hum Genet 78:82751
Najarian DJ, Gottlieb AB (2003) Connections between psoriasis and Crohns
disease. J Am Acad Dermatol 48:80521; quiz 822804
Nelson GW, Martin MP, Gladman D, Wade J, Trowsdale J, Carrington M
(2004) Cutting edge: heterozygote advantage in autoimmune disease:
hierarchy of protection/susceptibility conferred by HLA and killer Ig-like
receptor combinations in psoriatic arthritis. J Immunol 173:42736
Nestle FO, Conrad C, Tun-Kyi A, Homey B, Gombert M, Boyman O et al.
(2005) Plasmacytoid predendritic cells initiate psoriasis through interferon-{alpha} production. J Exp Med 202:13543
Nestle FO, Turka LA, Nickoloff BJ (1994) Characterization of dermal dendritic
cells in psoriasis. Autostimulation of T lymphocytes and induction of Th1
type cytokines. J Clin Invest 94:2029
Neurath MF (2007) IL-23: a master regulator in Crohn disease. Nat Med
13:268
Newcomb DC, Zhou W, Moore ML, Goleniewska K, Hershey GK, Kolls JK
et al. (2009) A functional IL-13 receptor is expressed on polarized murine
CD4+ Th17 cells and IL-13 signaling attenuates Th17 cytokine
production. J Immunol 182:531721
Nickoloff BJ (2001) Creation of psoriatic plaques: the ultimate tumor
suppressor pathway. A new model for an ancient T-cell-mediated skin
disease. Viewpoint. J Cutan Pathol 28:5764
Nickoloff BJ, Qin JZ, Nestle FO (2007) Immunopathogenesis of psoriasis. Clin
Rev Allergy Immunol 33:4556
Nickoloff BJ, Wrone-Smith T (1999) Injection of pre-psoriatic skin with CD4+
T cells induces psoriasis. Am J Pathol 155:14558
Nograles KE, Zaba LC, Guttman-Yassky E, Fuentes-Duculan J, Suarez-Farinas
M, Cardinale I et al. (2008) Th17 cytokines interleukin (IL)-17 and IL-22
modulate distinct inflammatory and keratinocyte-response pathways. Br
J Dermatol 159:1092102
Nograles KE, Zaba LC, Shemer A, Fuentes-Duculan J, Cardinale I, Kikuchi T
et al. (2009) IL-22-producing T22 T cells account for upregulated IL22 in atopic dermatitis despite reduced IL-17-producing TH17 T cells.
J Allergy Clin Immunol 123:124452 e1242
Nomura I, Goleva E, Howell MD, Hamid QA, Ong PY, Hall CF et al. (2003)
Cytokine milieu of atopic dermatitis, as compared to psoriasis, skin
prevents induction of innate immune response genes. J Immunol
171:32629
Steinman L (2007) A brief history of T(H)17, the first major revision in the T(H)1/
T(H)2 hypothesis of T cell-mediated tissue damage. Nat Med 13:13945
Stratis A, Pasparakis M, Rupec RA, Markur D, Hartmann K, ScharffetterKochanek K et al. (2006) Pathogenic role for skin macrophages in a
mouse model of keratinocyte-induced psoriasis-like skin inflammation.
J Clin Invest 116:2094104
Plenge RM, Cotsapas C, Davies L, Price AL, de Bakker PI, Maller J et al. (2007)
Two independent alleles at 6q23 associated with risk of rheumatoid
arthritis. Nat Genet 39:147782
Stuart P, Malick F, Nair RP, Henseler T, Lim H, Jenisch S et al. (2002) Analysis
of phenotypic variation in psoriasis as a function of age at onset and
family history. Arch Dermatol Res 294:20713
Tan AL, Benjamin M, Toumi H, Grainger AJ, Tanner SF, Emery P et al. (2007)
The relationship between the extensor tendon enthesis and the nail in
distal interphalangeal joint disease in psoriatic arthritis a highresolution MRI and histological study. Rheumatology (Oxford) 46:2536
www.jidonline.org 1225
JT Elder et al.
Immunology and Genetics of Psoriasis